EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Organometallic Half-Sandwich Complexes of 1,10-Phenanthroline Derivatives with Improved Solubility, Albumin-Binding, and Nanoformulation Potential Targeting Drug Resistance in Cancer

Egon F Várkonyi, Szilárd Tóth iD, Tamás Pivarcsik, Orsolya Dömötör, Ottó Berkesi, Nóra V May, Gergely Szakács, Edit Csapó, Éva A Enyedy iD

Inorganic Chemistry · 2025

DOI: 10.1021/acs.inorgchem.5c01556 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inorganic Chemistry, 2025. Verfasst von Egon F Várkonyi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Analytical Chemistry, Interdisciplinary Excellence Centre, University of Szeged, Dóm tér 7-8, H-6720 Szeged, Hungary. Hauptthemen laut MEDLINE: Antineoplastic Agents, Phenanthrolines, Coordination Complexes, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nemzeti Kutat?si, Fejleszt?si ?s Innovaci?s Alap, Austrian Science Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of Rh(III)(η5-C5Me5) and Ru(II)(η6-p-cymene) complexes of 4,7-dichloro-1,10-phenanthroline (DCP) and bathophenanthroline (BP) aims to increase aqueous solubility and potential bioavailability of the lipophilic ligands while also enabling selective activity against multidrug-resistant (MDR) cancer cells. Complexes [M(η6-arene/η5-arenyl)(DCP/BP)Cl]Cl were prepared and characterized by means of nuclear magnetic resonance, infrared, electrospray ionization mass spectrometry, and single crystal X-ray diffraction for [Rh(III)(η5-C5Me5)(DCP)Cl]PF6 and [Ru(II)(η6-p-cymene)(BP)Cl]PF6. The complexes are highly stable in a wide pH range with increased hydrophilicity, and the Rh complexes showed fast and significant binding to human serum albumin (HSA). Cytotoxicity tests were conducted in various breast cancer cells and in cocultured cell lines of the uterine sarcoma parental MES-SA and its MDR counterparts. Both the ligands and their organorhodium complexes displayed a higher cytotoxicity against the MDR MES-SA/Dx5 cells than against the parental cells. As the complex [Rh(III)(η5-C5Me5)(BP)Cl]Cl showed the most promising results (IC50 = 0.23 μM (MES-SA/Dx5) with selectivity ratio 6.7), it was selected for nanoformulation using HSA and also combined with d-α-tocopheryl polyethylene glycol 1000 succinate and poly(lactic-co-glycolic acid). Both composites showed a good encapsulation efficiency and colloidal stability. Based on the in vitro cytotoxicity assays, the use of HSA as a carrier is a promising strategy to enhance the pharmacological properties of the MDR-selective Rh(III)(η5-C5Me5) complexes of 1,10-phenanthroline derivatives.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsPhenanthrolinesCoordination ComplexesDrug Resistance, NeoplasmSerum Albumin, HumanHumansSolubilityCell Line, TumorDrug Screening Assays, AntitumorMolecular StructureRutheniumRhodiumCell ProliferationDrug Resistance, MultipleNanoparticles

Substanzen

Antineoplastic AgentsPhenanthrolinesCoordination Complexes1,10-phenanthrolineSerum Albumin, HumanRutheniumRhodium

Autor:innen und Institutionen

  • Department of Molecular and Analytical Chemistry, Interdisciplinary Excellence Centre, University of Szeged, Dóm tér 7-8, H-6720 Szeged, Hungary.
  • MTA-SZTE Lendület "Momentum" Noble Metal Nanostructures Research Group, University of Szeged, Rerrich B. Sqr. 1, H-6720 Szeged, Hungary.
  • Department of Physical Chemistry and Materials Science, Interdisciplinary Excellence Centre, University of Szeged, Rerrich B. Sqr. 1, H-6720 Szeged, Hungary.
  • Drug Resistance Research Group, Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Magyar Tudósok krt. 2, H-1117 Budapest, Hungary.
  • National Laboratory for Drug Research and Development, Magyar Tudósok krt. 2, H-1117 Budapest, Hungary.
  • Centre for Structural Science, HUN-REN Research Centre for Natural Sciences, Magyar Tudósok krt. 2, H-1117 Budapest, Hungary.

ORCID-Profile: Szilárd Tóth, Éva A Enyedy

Förderung

  • Nemzeti Kutat?si, Fejleszt?si ?s Innovaci?s Alap
  • Austrian Science Fund

Zitieren

APA

Várkonyi, E. F., Tóth, S., Pivarcsik, T., Dömötör, O., Berkesi, O., May, N. V., Szakács, G., Csapó, E., & Enyedy, É. A. (2025). Organometallic Half-Sandwich Complexes of 1,10-Phenanthroline Derivatives with Improved Solubility, Albumin-Binding, and Nanoformulation Potential Targeting Drug Resistance in Cancer. Inorganic Chemistry. https://doi.org/10.1021/acs.inorgchem.5c01556

Vancouver

Várkonyi EF, Tóth S, Pivarcsik T, Dömötör O, Berkesi O, May NV, et al. Organometallic Half-Sandwich Complexes of 1,10-Phenanthroline Derivatives with Improved Solubility, Albumin-Binding, and Nanoformulation Potential Targeting Drug Resistance in Cancer. Inorganic Chemistry. 2025. doi:10.1021/acs.inorgchem.5c01556

BibTeX
@article{Vrkonyi2025,
  author = {Várkonyi, Egon F and Tóth, Szilárd and Pivarcsik, Tamás and Dömötör, Orsolya and Berkesi, Ottó and May, Nóra V and Szakács, Gergely and Csapó, Edit and Enyedy, Éva A},
  title = {Organometallic Half-Sandwich Complexes of 1,10-Phenanthroline Derivatives with Improved Solubility, Albumin-Binding, and Nanoformulation Potential Targeting Drug Resistance in Cancer},
  journal = {Inorganic Chemistry},
  year = {2025},
  doi = {10.1021/acs.inorgchem.5c01556}
}
Kostenlos starten →